申请人:Merck Frosst Canada, Inc.
公开号:US05639780A1
公开(公告)日:1997-06-17
The invention encompasses the novel compound of Formula I useful in the treatment of cyclooxygenase-2 mediated diseases. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I.
本发明涵盖了具有式I的新型化合物,其在治疗环氧合酶-2介导的疾病中非常有用。 ##STR1## 本发明还涵盖了某些药物组合物,用于治疗环氧合酶-2介导的疾病,包括式I的化合物。